Results 41 to 50 of about 109,215 (254)

Thrombotic Microangiopathy and the Kidney [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2017
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI. It can be associated with significant morbidity and mortality, but a systematic approach to investigation and prompt initiation of supportive management and, in some cases ...
Brocklebank V, Wood KM, Kavanagh D
openaire   +3 more sources

Assembly and Activation of Alternative Complement Components on Endothelial Cell-Anchored Ultra-Large Von Willebrand Factor Links Complement and Hemostasis-Thrombosis [PDF]

open access: yes, 2013
Background: Vascular endothelial cells (ECs) express and release protein components of the complement pathways, as well as secreting and anchoring ultra-large von Willebrand factor (ULVWF) multimers in long string-like structures that initiate platelet ...
Moake, Joel, Turner, Nancy A.
core   +2 more sources

A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab [PDF]

open access: yes, 2016
Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving ...
Kirui, Nicholas, Sokwala, Ahmed
core   +4 more sources

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies. [PDF]

open access: yesDtsch Arztebl Int, 2018
Bommer M   +3 more
europepmc   +2 more sources

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics

open access: yesFrontiers in Immunology, 2019
Thrombotic microangiopathies (TMAs) are a heterogeneous group of syndromes presenting with a distinct clinical triad: microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
E. Gavriilaki   +2 more
semanticscholar   +1 more source

Difficulties in diagnostics of atypical hemolytic uremic syndrome in the intensive care unit

open access: yesВестник анестезиологии и реаниматологии, 2019
Atypical hemolytic uremic syndrome (aHUS) is an orphan disease, representing one of thrombotic microangiopathies, the natural course of which leads to an unfavorable outcome often accompanied by multiple organ failure in the onset of the disease ...
N. L. Kozlovskаya   +2 more
doaj   +1 more source

Histopathological features of thrombotic microangiopathies in renal biopsies [PDF]

open access: yesJournal of Nephropathology, 2019
Background: Thrombotic microangiopathy (TMA) is a morphologic lesion characterized by thrombi occluding microvasculature related to endothelial injury. Objectives: This study aimed to assess the association between histopathological findings and etiology
Miguel Ernandes Neto   +5 more
doaj   +1 more source

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report [PDF]

open access: yes, 2015
INTRODUCTION: Thrombotic microangiopathies are a group of diseases presenting as microangiopathic hemolytic anemia, thrombocytopenia and end-organ dysfunction.
Abdulkadir Unsal   +11 more
core   +1 more source

The PLASMIC Score May Be Useful in the Early Diagnosis of Complement-Mediated Thrombotic Microangiopathy via Early Exclusion of Thrombotic Thrombocytopenic Purpura

open access: yesCase Reports in Medicine, 2019
Complement-mediated thrombotic microangiopathy is a rare form of thrombotic microangiopathy but has high rates of mortality and morbidity. Effective treatment exists with eculizumab for this condition, but administration of treatment is often delayed ...
Edwin Lu, Willie Moore
doaj   +1 more source

Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura

open access: yesHematology Reports, 2023
Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening, rare acute thrombotic microangiopathy (TMA), caused by a severe ADAMTS13 deficiency.
Antonella Bruzzese   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy